Adjunctive Docosahexaenoic Acid in Residual Symptoms of Depression and Anxiety

Outcomes of Online Mindfulness-Based Cognitive Therapy for Patients With Residual Depressive Symptoms

(2020) Zindel V. Segal et al.   JAMA Psychiatry

Efficacy of omega-3 PUFAs in depression: A meta-analysis

(2019) Yuhua Liao et al.   Translational Psychiatry

Sex differences in antidepressant efficacy

(2018) Tara A. LeGates et al.   NEUROPSYCHOPHARMACOLOGY

Adjunctive low-dose docosahexaenoic acid (DHA) for major depression: An open-label pilot trial

(2017) Deidre J. Smith et al.   NUTRITIONAL NEUROSCIENCE

Efficacy of omega-3 highly unsaturated fatty acids in the treatment of depression

(2016) Brian Hallahan et al.   BRITISH JOURNAL OF PSYCHIATRY

Preclinical sex differences in depression and antidepressant response: Implications for clinical research

(2016) Nikolaos Kokras et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Complementary and alternative therapies as add-on to pharmacotherapy for mood and anxiety disorders: A systematic review

(2013) Arun V. Ravindran et al.   JOURNAL OF AFFECTIVE DISORDERS

Omega-3 Fatty Acid Augmentation of Citalopram Treatment for Patients With Major Depressive Disorder

(2011) Lev Gertsik et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder

(2008) David Mischoulon et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

The impact of analytic method on interpretation of outcomes in longitudinal clinical trials

(2008) A. Prakash et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE